Remove Data Remove Media Remove Presentation Remove Safety
article thumbnail

GemmaCert: Scientific Study Reveals Major Deviation Between Labelled and Actual CBD Potency in Commercial Products

Puff Puff Post

These results raise safety and efficacy concerns. The findings will be presented at the 20 th International Congress of the International Society for Ethnopharmacology to be held in Thessaloniki, Greece , in April 2020. Media Contact: Hadas Weizman hadas@marcomm.co.il +972(0)54-6077622. TEL AVIV, Israel , Feb.

CBD 96
article thumbnail

Press Release: Delic Announces Medical Advisory Board, Demonstrates Psychedelic Wellness Company’s Commitment to Science

Cannabis Law Report

The Board will advise Delic and its subsidiaries, including Ketamine Infusion Centers, Delic Labs and others, as they develop safety protocols and best practices pertaining to legal psychedelic wellness treatments today and those legalized in the future. Chris Ray , PhD : Interventional Pain Physician.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

New- ANH-Intl Special Report: Is safety the new gremlin for CBD regulation?

Cannabis Law Report

We take a look at where CBD regulation might be going and whether we should be concerned about safety writes Rob Verkerk PhD, scientific and executive director, ANH-Intl. We take a look at where CBD regulation might be going and whether we should be concerned about safety. A new ‘problem’: safety. ? A new ‘problem’: safety.

Safety 59
article thumbnail

FDA Publish Article “5 Things to Know about Delta-8 Tetrahydrocannabinol – Delta-8 THC”

Cannabis Law Report

From December 2020 through July 2021, the FDA received adverse event reports from both consumers and law enforcement describing 22 patients who consumed delta-8 THC products; of these, 14 presented to a hospital or emergency room for treatment following the ingestion. brownies, gummies). exposures to any substance(s).

THC 105
article thumbnail

Here’s what you need to know about cannabis research

The Cannigma

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. What if most of it is not based on the level of scientific certainty that cannabis marketing teams and media outlets would have us believe? Recent data suggest the US science knowledge is about the global average.

article thumbnail

Goldfinch Bio Announces Upcoming Presentations at American Society of Human Genetics (ASHG) 2021 Meeting and American Society of Nephrology’s (ASN) Kidney Week 2021

Cannabis Law Report

At ASHG, Goldfinch Bio will give an oral presentation showcasing insights revealed by its Kidney Genome Atlas (KGA). At ASHG, Goldfinch Bio will give an oral presentation showcasing insights revealed by its Kidney Genome Atlas (KGA). Both meetings are being held virtually. President and Chief Executive Officer of Goldfinch Bio. “In

article thumbnail

Press Release: COMPASS Pathways plc financial results second quarter 2021 – Reminds us of that rich people’s festival in the desert

Cannabis Law Report

Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. On track to report top-line data by end of 2021. Net loss for the six months ended 30 June 2021 was $30.2 million, or $0.79 million) compared with $24.8 million, or $2.61